Eukaryotic mitochondria resulted from symbiotic incorporation of α-proteobacteria into ancient archaea species. During evolution, mitochondria lost most of the prokaryotic bacterial genes and only conserved a small fraction including those encoding 13 proteins of the respiratory chain. In this process, many functions were transferred to the host cells, but mitochondria gained a central role in the regulation of cell proliferation and apoptosis, and in the modulation of metabolism; accordingly, defective organelles contribute to cell transformation and cancer, diabetes, and neurodegenerative diseases. Most cell and transcriptional effects of mitochondria depend on the modulation of respiratory rate and on the production of hydrogen peroxide released into the cytosol. The mitochondrial oxidative rate has to remain depressed for cell proliferation; even in the presence of O2, energy is preferentially obtained from increased glycolysis (Warburg effect). In response to stress signals, traffic of pro- and antiapoptotic mitochondrial proteins in the intermembrane space (B-cell lymphoma-extra large, Bcl-2-associated death promoter, Bcl-2 associated X-protein and cytochrome c) is modulated by the redox condition determined by mitochondrial O2 utilization and mitochondrial nitric oxide metabolism. In this article, we highlight the traffic of the different canonical signaling pathways to mitochondria and the contributions of organelles to redox regulation of kinases. Finally, we analyze the dynamics of the mitochondrial population in cell cycle and apoptosis. Antioxid. Redox Signal. 16, 1150–1180.
AffaitatiA, CardoneL, CarlucciA, de CristofaroT, GinsbergMD, VarroneS, GottesmanME, AvvedimentoVE, FelicielloA. Essential role of A-kinase anchor protein 121 for cAMP signaling to mitochondria. J Biol Chem, 278:4286–4294. 2003.
3.
AhmedNN, GrimesHL, BellacosaA, ChanTO, TsichlisPN. Transduction of interleukin-2 antiapoptotic and proliferative signals via Akt protein kinase. Proc Natl Acad Sci U S A, 94:3627–3632. 1997.
4.
AlmeidaA, BolañosJP, MoncadaS. E3 ubiquitin ligase APC/C-Cdh1 accounts for the Warburg effect by linking glycolysis to cell proliferation. Proc Natl Acad Sci U S A, 107:738–741. 2010.
AltoNM, SoderlingJ, ScottJD. Rab32 is an A-kinase anchoring protein and participates in mitochondrial dynamics. J Cell Biol, 158:659–668. 2002.
7.
AmbsS, HussainSP, HarrisCC. Interactive effects of nitric oxide and the p53 tumor suppressor gene in carcinogenesis and tumor progression. FASEB J, 11:443–448. 1997.
8.
AnjumR, BlenisJ. The RSK family of kinases: emerging roles in cellular signalling. Nature Rev, 9:747–758. 2008.
9.
Antico ArciuchVG, AlippeY, CarrerasMC, PoderosoJJ. Mitochondrial kinases in cell signaling: facts and perspectives. Adv Drug Deliv Rev, 61:1234–1249. 2009.
10.
Antico ArciuchVG, DimaM, LiaoXH, RefetoffS, Di CristofanoA. Cross-talk between PI3K and estrogen in the mouse thyroid predisposes to the development of follicular carcinomas with a higher incidence in females. Oncogene, 29:5678–5686. 2010.
11.
Antico ArciuchVG, GalliS, FrancoMC, LamPY, CadenasE, CarrerasMC, PoderosoJJ. Akt1 intramitochondrial cycling is a crucial step in the redox modulation of cell cycle progression. PLoS One, 4:e7523. 2009.
12.
BaldwinASJr.The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol, 14:649–683. 1996.
BasuA, LuD, SunB, MoorAN, AkkarajuGR, HuangJ. Proteolytic activation of protein kinase C-epsilon by caspase-mediated processing and transduction of antiapoptotic signals. J Biol Chem, 277:41850–41856. 2002.
15.
BermanSB, ChenYB, QiB, McCafferyJM, RuckerEB3rd, GoebbelsS, NaveKA, ArnoldBA, JonasEA, PinedaFJ, HardwickJM. Bcl-x L increases mitochondrial fission, fusion, and biomass in neurons. J Cell Biol, 184:707–719. 2009.
16.
BijurGN, JopeRS. Rapid accumulation of Akt in mitochondria following phosphatidylinositol 3-kinase activation. J Neurochem, 87:1427–1435. 2003.
17.
Bossy-WetzelE, TalantovaMV, LeeWD, ScholzkeMN, HarropA, MathewsE, GotzT, HanJ, EllismanMH, PerkinsGA, LiptonSA. Crosstalk between nitric oxide and zinc pathways to neuronal cell death involving mitochondrial dysfunction and p38-activated K+ channels. Neuron, 41:351–365. 2004.
18.
BoverisA, OshinoN, ChanceB. The cellular production of hydrogen peroxide. Biochem J, 128:617–630. 1972.
19.
BoverisA, CadenasE, StoppaniAO. Role of ubiquinone in the mitochondrial generation of hydrogen peroxide. Biochem J, 56:435–444. 1976.
20.
BrandA, HermfisseU. Aerobic glycolysis by proliferating cells: a protective strategy against reactive oxygen species. FASEB J, 11:388–395. 1997.
21.
BrennanJP, BardswellSC, BurgoyneJR, FullerW, SchröderE, WaitR, BegumS, KentishJC, EatonP. Oxidant–induced activation of type I protein kinase A is mediated by RI subunit interprotein disulfide bond formation. J Biol Chem, 281:21827–21836. 2006.
22.
BurdonRH, AllianganaD, GillV. Hydrogen peroxide and the proliferation of BHK-21 cells. Free Radic Res, 23:471–486. 1995.
23.
BurgeringBM, KopsGJ. Cell cycle and death control: long live Forkheads. Trends Biochem Sci, 27:352–360. 2002.
24.
BurhansWC, HeintzNH. The cell cycle is a redox cycle: Linking phase-specific targets to cell fate. Free Rad Biol Med, 47:1282–1293. 2009.
25.
BurkRF, NishikiK, LawrenceRA, ChanceB. Peroxide removal by selenium-dependent and selenium-independent gluthatione peroxidases in hemoglobin-free perfused rat liver. J Biol Chem, 253:43–46. 1978.
26.
BustamanteE, PedersenPL. High aerobic glycolysis of rat hepatoma cells in culture: role of mitochondrial hexokinase. Proc Natl Acad Sci U S A, 74:3735–3739. 1977.
27.
BustamanteE, MorrisHP, PedersenPL. Energy metabolism of tumor cells. Requirement for a form of hexokinase with a propensity for mitochondrial binding. J Biol Chem, 256:8699–8704. 1981.
CagnolS, ChambardJC. ERK and cell death: mechanisms of ERK-induced cell death—apoptosis, autophagy and senescence. FEBS J, 277:2–21. 2010.
30.
CantóC, AuwerxJ. PGC-1alpha, SIRT1 and AMPK, an energy sensing network that controls energy expenditure. Curr Opin Lipidol, 20:98–105. 2009.
31.
CantóC, AuwerxJ. AMP-activated protein kinase and its downstream transcriptional pathways. Cell Mol Life Sci, 67:3407–3423. 2010.
32.
CarrerasMC, PoderosoJJ. Mitochondrial nitric oxide in the signaling of cell integrated responses. Am J Physiol Cell Physiol, 292:1569–1580. 2007.
33.
CarrerasMC, ConversoDP, LorenteAS, BarbichMR, LevismanDM, JaitovichA, Antico ArciuchVG, GalliS, PoderosoJJ. Mitochondrial nitric oxide synthase drives redox signals from proliferation and quiescence in rat liver development. Hepatology, 40:157–166. 2004.
34.
CarrerasMC, FrancoMC, PeraltaJG, PoderosoJJ. Nitric oxide, complex I, and the modulation of mitochondrial reactive species in biology and disease. Mol Aspects Med, 25:125–139. 2004.
35.
CereghettiGM, CostaV, ScorranoL. Inhibition of Drp1-dependent mitochondrial fragmentation and apoptosis by a polypeptide antagonist of calcineurin. Cell Death Differ, 17:1785–1794. 2010.
36.
ChanTO, RittenhouseSE, TsichlisPN. AKT/PKB and other D3 phosphoinositideregulated kinases: kinase activation by phosphoinositide-dependent phosphorylation. Annu Rev Biochem, 68:965–1014. 1999.
37.
ChangCR, BlackstoneC. Dynamic regulation of mitochondrial fission through modification of the dynamin-related protein Drp1. N Y Acad Sci, 1201:34–39. 2010.
38.
ChenH, ChanDC. Emerging functions of mammalian mitochondrial fusion and fission. Hum Mol Genet, 14:R283–R289. 2005.
39.
ChenHZ, TsaiSY, LeoneG. Emerging roles of E2Fs in cancer: an exit from cell cycle control. Nat Rev Cancer, 9:785–797. 2009.
ChenR, FearnleyIM, Peak-ChewSY, WalkerJE. The phosphorylation of subunits of complex I from bovine heart mitochondria. J Biol Chem, 279:26036–26045. 2004.
42.
ChenRH, SarneckiC, BlenisJ. Nuclear localization and regulation of erk- and rsk-encoded protein kinases. Mol Cell Biol, 12:915–927. 1992.
43.
ChenWS, XuPZ, GottlobK, ChenML, SokolK, ShiyanovaT, RoninsonI, WengW, SuzukiR, TobeK, KadowakiT, HayN. Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. Genes Dev, 15:2203–2208. 2001.
44.
ChipukJE, Bouchier-HayesL, GreenDR. Mitochondrial outer membrane permeabilization during apoptosis: the innocent bystander scenario. Cell Death Differ, 13:1396–1402. 2006.
45.
ChoDH, NakamuraT, FangJ, CieplakP, GodzikA, GuZ, LiptonSA. S-nitrosylation of Drp1 mediates β-amyloid-related mitochondrial fission and neuronal injury. Science, 324:102–105. 2009.
46.
ChoH, ThorvaldsenJL, ChuQ, FengF, BirnbaumMJ. Akt1/pkbalpha is required for normal growth but dispensable for maintenance of glucose homeostasis in mice. J Biol Chem, 276:38349–38352. 2001.
47.
ChoYM, KwonS, PakYK, SeolHW, ChoiYM, Park doJ, ParkKS, LeeHK. Dynamic changes in mitochondrial biogenesis and antioxidant enzymes during the spontaneous differentiation of human embryonic stem cells. Biochem Biophys Res Commun, 348:1472–1478. 2006.
48.
ChoiBM, PaeHO, JangSI, KimYM, ChungHT. Nitric oxide as a pro-apoptotic as well as anti-apoptotic modulator. J Biochem Mol Biol, 35:116–126. 2002.
49.
ChowdhuryR, McDonoughMA, MecinovićJ, LoenarzC, FlashmanE, HewitsonKS, DomeneC, SchofieldCJ. Structural basis for binding of hypoxia-inducible factor to the oxygen-sensing prolyl hydroxylases. Structure, 17:981–989. 2009.
50.
ChurchillEN, Mochly-RosenD. The roles of PKCdelta and epsilon isoenzymes in the regulation of myocardial ischaemia/reperfusion injury. Biochem Soc Trans, 35:1040–1042. 2007.
51.
ClarkJ, SimonDK. Transcribe to survive: transcriptional control of antioxidant defense programs for neuroprotection in Parkinson's disease. Antioxid Redox Signal, 11:509–528. 2009.
52.
CopelandWC, WachsmanJT, JohnsonFM, PentaJS. Mitochondrial DNA alterations in cancer. Cancer Invest, 20:557–569. 2002.
53.
CovelloKL, KehlerJ, YuH, GordanJD, ArshamAM, HuCJ, LaboskyPA, SimonMC, KeithB. HIF-2alpha regulates Oct-4: effects of hypoxia on stem cell function, embryonic development, and tumor growth. Genes Dev, 20:557–570. 2006.
54.
Dali-YoucefN, MatakiC, CosteA, MessaddeqN, GiroudS, BlancS, KoehlC, ChampyMF, ChambonP, FajasL, MetzgerD, SchoonjansK, AuwerxJ. Adipose tissue-specific inactivation of the retinoblastoma protein protects against diabesity because of increased energy expenditure. Proc Natl Acad Sci U S A, 104:10703–10708. 2007.
55.
DattaSR, BrunetA, GreenbergME. Cellular survival: a play in three Akts. Genes Dev, 13:2905–2927. 1999.
56.
de BritoOM, ScorranoL. Mitofusin 2 tethers endoplasmic reticulum (ER) to mitochondria. Nature, 456:605–610. 2008.
57.
De RasmoD, PanelliD, SardanelliAM, PapaS. cAMP-dependent protein kinase regulates the mitochondrial import of the nuclear encoded NDUFS4 subunit of complex I. Cell Signal, 20:989–997. 2008.
58.
de RooijJ, ZwartkruisFJ, VerheijenMH, CoolRH, NijmanSM, WittinghoferA, BosJL. Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature, 396:474–477. 1998.
59.
De VosKJ, AllanVJ, GriersonAJ, SheetzMP. Mitochondrial function and actin regulate dynamin-related protein 1-dependent mitochondrial fission. Curr Biol, 15:678–683. 2005.
60.
DeshpandeA, SicinskiP, HindsPW. Cyclins and cdks in development and cancer: a perspective. Oncogene, 24:2909–2915. 2005.
61.
DiazF, MoraesCT. Mitochondrial biogenesis and turnover. Cell Calcium, 44:24–35. 2008.
EzashiT, DasP, RobertsRM. Low O2 tensions and the prevention of differentiation of hES cells. Proc Natl Acad Sci U S A, 102:4783–4788. 2005.
65.
FadeelB, OrreniusS. Apoptosis: a basic biological phenomenon with wide-ranging implications in human disease. J Intern Med, 258:479–517. 2005.
66.
FelicielloA, GottesmanME, AvvedimentoEV. The biological functions of A-kinase anchor proteins. J Mol Biol, 308:99–114. 2001.
67.
FernandezE, CuencaN, GarciaM, De JuanJ. Two types of mitochondria are evidenced by protein kinase C immunoreactivity in the Muller cells of the carp retina. Neurosci Lett, 183:202–205. 1995.
68.
FinocchiettoPV, BarreyroF, HolodS, PeraltaJG, FrancoMC, MéndezC, ConversoDP, EstévezAG, CarrerasMC, PoderosoJJ. Control of Muscle Mitochondria by Insulin Entails Activation of Akt2-mtNOS Pathway: Implications for the Metabolic Syndrome. PLoS ONE, 3:e1749. 2008.
69.
FinocchiettoPV, FrancoMC, HolodSA, GonzalezAS, ConversoDP, Antico ArciuchVG, SerraMP, PoderosoJJ, CarrerasMC. Mitochondrial nitric oxide synthase: a master piece of metabolic adaptation, cell growth, transformation and death. Exp Biol Med (Maywood), 234:1020–1028. 2009.
70.
FinocchiettoPV, HolodSA, BarreyroF, PeraltaJG, AlippeY, GiovambattistaA, CarrerasMC, PoderosoJJ. Defective leptin-AMPK pathway induces NO release and contributes to mitochondrial dysfunction and obesity in ob/ob Mice. Antioxid Redox Signal, 15:2395–2406. 2011.
71.
FosterMW, HessDT, StamlerJS. Protein S-nitrosylation in health and disease: a current perspective. Trends Mol Med, 15:391–404. 2009.
72.
FrancoMC, Antico ArciuchVG, PeraltaJG, GalliS, LevismanD, LópezLM, RomoriniL, PoderosoJJ, CarrerasMC. Hypothyroid phenotype is contributed by mitochondrial complex I inactivation due to translocated neuronal nitric oxide synthase. J Biol Chem, 281:4779–4786. 2006.
73.
FrankS, GaumeB, Bergmann-LeitnerES, LeitnerWW, RobertEG, CatezF, SmithCL, YouleRJ. The role of dynamin-related protein 1, a mediator of mitochondrial fission, in apoptosis. Dev Cell, 1:515–525. 2001.
74.
FrankeTF, YangSI, ChanTO, DattaK, KazlauskasA, MorrisonDK, KaplanDR, TsichlisPN. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell, 2:727–736. 1995.
75.
FrezzaC, CipolatS, Martins de BritoO, MicaroniM, BeznoussenkoGV, RudkaT, BartoliD, PolishuckRS, DanialNN, De StrooperB, ScorranoL. OPA1 controls apoptotic cristae remodeling independently from mitochondrial fusion. Cell, 126:177–189. 2006.
76.
FritzV, FajasL. Metabolism and proliferation share common regulatory pathways in cancer cells. Oncogene, 29:4369–4377. 2010.
77.
FujinoaG, NoguchiaT, TakedaaK, IchijoH. Thioredoxin and protein kinases in redox signaling. Sem Cancer Biol, 16:427–435. 2006.
78.
GalliS, LabatoMI, Bal de Kier JofféE, CarrerasMC, PoderosoJJ. Decreased mitochondrial nitric oxide synthase activity and hydrogen peroxide relate persistent tumoral proliferation to embryonic behavior. Cancer Res, 63:6370–6377. 2003.
79.
GalliS, Antico ArciuchVG, PoderosoC, ConversoDP, ZhouQ, Bal de Kier JofféE, CadenasE, BoczkowskiJ, CarrerasMC, PoderosoJJ. Tumor cell phenotype is sustained by selective MAPK oxidation in mitochondria. PLoS One, 3:e2379. 2008.
80.
GalliS, JahnO, HittR, HesseD, OpitzL, PlessmannU, UrlaubH, PoderosoJJ, Jares-ErijmanEA, JovinTM. A new paradigm for MAPK: structural interactions of hERK1 with mitochondria in HeLa cells. PLoS One., 4:e7541. 2009.
81.
GardaiSJ, HildemanDA, FrankelSK, WhitlockBB, FraschSC, BorregaardN, MarrackP, BrattonDL, HensonPM. Phosphorylation of Bax Ser184 by Akt regulates its activity and apoptosis in neutrophils. J Biol Chem, 279:21085–21095. 2004.
82.
GarridoN, GriparicL, JokitaloE, WartiovaaraJ, van der BliekAM, SpelbrinkJN. Composition and dynamics of human mitochondrial nucleoids. Mol Biol Cell, 14:1583–1596. 2003.
83.
GatenbyRA, GilliesRJ. Why do cancers have high aerobic glycolysis?Nat Rev Cancer, 4:891–899. 2004.
84.
GerschmanR, GilbertDL, NyeSW, DwyerP, FennWO. Oxygen poisoning and X-irradiation: a mechanism in common. Science, 119:623–626. 1954.
85.
GingrasAC, KennedySG, O'LearyMA, SonenbergN, HayN. 4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt (PKB) signaling pathway. Genes Dev, 12:502–513. 1998.
86.
GinsbergMD, FelicielloA, JonesJK, AvvedimentoEV, GottesmanME. PKA-dependent binding of mRNA to the mitochondrial AKAP121 protein. J Mol Biol, 327:885–897. 2003.
87.
GreerEL, BrunetA. FOXO transcription factors at the interface between longevity and tumor suppression. Oncogene, 24:7410–7425. 2005.
88.
GregersenN, BrossP. Protein misfolding and cellular stress: an overview. Methods Mol Biol, 648:3–23. 2010.
89.
HajriA, MetzgerE, VallatF, CoffyS, FlatterE, EvrardS, MarescauxJ, AprahamianM. Role of nitric oxide in pancreatic tumour growth: in vivo and in vitro studies. Br J Cancer, 78:841–849. 1998.
90.
HanMK, SongEK, GuoY, OuX, MantelC, BroxmeyerHE. SIRT1 regulates apoptosis and Nanog expression in mouse embryonic stem cells by controlling p53 subcellular localization. Cell Stem Cell, 2:241–251. 2008.
91.
HaoZ, DuncanGS, ChangCC, EliaA, FangM, WakehamA, OkadaH, CalzasciaT, JangY, You-TenA, YehWC, OhashiP, WangX, MakTW. Specific ablation of the apoptotic functions of cytochrome c reveals a differential requirement for cytochrome c and Apaf-1 in apoptosis. Cell, 121:579–591. 2005.
92.
HaradaH, BecknellB, WilmM, MannM, HuangLJ, TaylorSS, ScottJD, KorsmeyerS. Phosphorylation and inactivation of BAD by mitochondria-anchored protein kinase A. J Mol Cell, 4:413–422. 1999.
93.
HarderZ, ZuninoR, McBrideH. Sumo1 conjugates mitochondrial substrates and participates in mitochondrial fission. Curr Biol, 14:340–345. 2004.
HelinK. Regulation of cell proliferation by the E2F transcription factors. Curr Opin Genet Dev, 8:28–35. 1998.
96.
HollandHD. Early proterozoic atmospheric change. Early Life on Earth. BengtsonS. New York: Columbia University Press, 1994; 237–244.
97.
HolmesWF, SopranoDR, SopranoKJ. Early events in the induction of apoptosis in ovarian carcinoma cells by CD437: activation of the p38 MAP kinase signal pathway. Oncogene, 22:6377–6386. 2003.
98.
HolmgrenA, LuJ. Thioredoxin and thioredoxin reductase: current research with special reference to human disease. Biochem Biophys Res Commun, 396:120–124. 2010.
99.
HortelanoS, AlvarezAM, BoscaL. Nitric oxide induces tyrosine nitration and release of cytochrome c preceding an increase of mitochondrial transmembrane potential in macrophages. FASEB J, 13:2311–2317. 1999.
100.
HoughtonFD. Energy metabolism of the inner cell mass and trophectoderm of the mouse blastocyst. Differentiation, 74:11–18. 2006.
101.
HsiehMC, DasD, SambandamN, ZhangMQ, NahleZ. Regulation of the PDK4 isozyme by the Rb–E2F1 complex. J Biol Chem, 283:27410–27417. 2008.
102.
HuJ, DongL, OuttenCE. The redox environment in the mitochondrial intermembrane space is maintained separately from the cytosol and matrix. J Biol Chem, 283:29126–29134. 2008.
103.
HuangJS, ChuangLY, GuhJY, ChenCJ, YangYL, ChiangTA, HungMY, LiaoTN. Effect of nitric oxide-cGMP-dependent protein kinase activation on advanced glycation end-product-induced proliferation in renal fibroblasts. J Am Soc Nephrol, 16:231–239. 2005.
104.
HuangP, YuT, YoonY. Mitochondrial clustering induced by overexpression of the mitochondrial fusion protein Mfn2 causes mitochondrial dysfunction and cell death. Eur J Cell Biol, 86:289–302. 2007.
105.
HuoL, ScarpullaRC. Mitochondrial DNA instability and peri-implantation lethality associated with targeted disruption of nuclear respiratory factor 1 in mice. Mol Cell Biol, 21:644–654. 2001.
106.
HydeBB, TwigG, ShirihaiOS. Organellar vs cellular control of mitochondrial dynamics. Semin Cell Dev Biol, 21:575–581. 2010.
107.
IkenoueT, InokiK, YangQ, ZhouX, GuanKL. Essential function of TORC2 in PKC and Akt turn motif phosphorylation, maturation and signaling. EMBO J, 23:1919–1931. 2008.
108.
IñarreaP, MoiniH, HanD, RettoriD, AguilóI, AlavaMA, IturraldeM, CadenasE. Mitochondrial respiratory chain and thioredoxin reductase regulate intermembrane Cu,Zn-superoxide dismutase activity: implications for mitochondrial energy metabolism and apoptosis. Biochem J, 405:173–179. 2007.
109.
IshidaA, SasaguriT, KosakaC, NojimaH, OgataJ. Induction of the cyclindependent kinase inhibitor p21Sdi1Cip1/Waf1 by nitric oxide-generating vasodilator in vascular smooth muscle cells. J Biol Chem, 272:10050–10057. 1999.
110.
JacobsKM, PenningtonJD, BishtKS, Aykin-BurnsN, KimHS, MishraM, SunL, NguyenP, AhnBH, LeclercJ, DengCX, SpitzDR, GiusD. SIRT3 interacts with the daf-16 homolog FOXO3a in the mitochondria, as well as increases FOXO3a dependent gene expression. Int J Biol Sci, 4:291–299. 2008.
111.
JaegerW. Hereditary optic atrophy with dominant transmission; with special reference to the associated color-sense disorder. Albrecht Von Graefes Arch Ophthalmol, 155:457–484. 1954.
112.
JezekP, Plecita-HlavataL, SmolkovaK, RossignolR. Distinctions and similarities of cell bioenergetics and the role of mitochondria in hypoxia, cancer, and embryonic development. Int J Biochem Cell Biol, 42:604–622. 2010.
113.
JinK, MaoXO, ZhuY, GreenbergDA. MEK and ERK protect hypoxic cortical neurons via phosphorylation of Bad. J Neurochem, 80:119–125. 2002.
KahanC, SeuwenK, MelocheS, PouysségurJ. Coordinate, biphasic activation of p44 mitogen-activated protein kinase and S6 kinase by growth factors in hamster fibroblasts. Evidence for thrombin-induced signals different from phosphoinositide turnover and adenylylcyclase inhibition. J Biol Chem, 267:13369–13375. 1992.
116.
KamataH, HondaS, MaedaS, ChangL, HirataH, KarinM. Reactive oxygen species promote TNF-alpha-induced death and sustained JNK activation by inhibiting MAP kinase death. Cell, 120:649–661. 2005.
117.
KarbowskiM, NorrisKL, ClelandMM, JeongSY, YouleRJ. Role of Bax and Bak in mitochondrial morphogenesis. Nature, 443:658–662. 2006.
118.
KashiwakuraI, KuwabaraM, MurakamiM, HayaseY, TakagiY. Effect of carboxy-PTIO, a nitric oxide scavenger, on the proliferation of murine hematopoietic progenitor cells in vitro. Res Commun Mol Pathol Pharmacol, 99:329–337. 1998.
KienhöferJ, HäusslerDJ, RuckelshausenF, MuessigE, WeberK, PimentelD, UllrichV, BürkleA, BachschmidMM. Association of mitochondrial antioxidant enzymes with DNA as integral nucleoid constituents. FASEB J., 23:2034–2044. 2009.
121.
KimAH, YanoH, ChoH, MeyerD, MonksB, MargolisB, BirnbaumMJ, ChaoMV. Akt1 regulates a JNK scaffold during excitotoxic apoptosis. Neuron, 35:697–709. 2002.
122.
KlimovaT, ChandelNS. Mitochondrial complex III regulates hypoxic activation of HIF. Cell Death Differ, 15:660–666. 2008.
123.
KnottAB, Bossy-WetzelE. Impact of nitric oxide on metabolism in health and age-related disease. Diabetes Obes Metabol, 12:126–133. 2010.
KolchW. Coordinating ERK/MAPK signalling through scaffolds and inhibitors. Nature Rev, 6:827–837. 2005.
126.
KondoN, NakamuraH, MasutaniH, YodoiJ. Redox regulation of human thioredoxin network. Antiox Redox Signal, 8:1881–1890. 2006.
127.
KongX, WangR, XueY, LiuX, ZhangH, ChenY, FangF, ChangY. Sirtuin 3, a New Target of PGC-1a, Plays an Important Role in the Suppression of ROS and Mitochondrial Biogenesis. PLoS One, 5:e11707. 2010.
128.
KurlandCG, AnderssonSGE. Origin and evolution of the mitochondrial proteome. Microbiol Mol Biol Rev, 64:786–820. 2000.
LebedevaMA, EatonJS, ShadelGS. Loss of p53 causes mitochondrial DNA depletion and altered mitochondrial reactive oxygen species homeostasis. Biochim Biophys Acta, 1787:328–334. 2009.
131.
LeberB, LinJ, AndrewsDW. Embedded together: the life and death consequences of interaction of the Bcl-2 family with membranes. Apoptosis, 12:897–911. 2007.
LiesaM, PalacínM, ZorzanoA. Mitochondrial dynamics in mammalian health and disease. Physiol Rev, 89:799–845. 2009.
137.
LiuB, ChenY, St. ClairDK. ROS and p53: versatile partnership. Free Rad Biol Med, 44:1529–1535. 2008.
138.
LiuG, LozanoG. p21 stability: linking chaperones to a cell cycle checkpoint. Cancer Cell, 7:113–114. 2005.
139.
LuD, SivaprasadU, HuangJ, ShankarE, MorrowS, BasuA. Protein kinase C-epsilon protects MCF-7 cells from TNF-mediated cell death by inhibiting Bax translocation. Apoptosis, 12:1893–1900. 2007.
140.
LuQ, Jourd'HeuilFL, Jourd'HeuilD. Redox control ofG1/S cell cycle regulators during nitric oxide-mediated cell cycle arrest. J Cell Physiol, 212:827–839. 2007.
141.
MalstromS, TiliE, KappesD, CeciJD, TsichlisPN. Tumor induction by an Lck-MyrAkt transgene is delayed by mechanisms controlling the size of the thymus. Proc Natl Acad Sci U S A, 98:14967–14972. 2001.
142.
MargulisL. Symbiotic theory of the origin of eukaryotic org anelles; criteria for proof. Symp Soc Exp Biol, 29:21–38. 1975.
143.
Martınez-DiezM, SantamarıaG, OrtegaA'D, CuezvaJM. Biogenesis and Dynamics of Mitochondria during the Cell Cycle: Significance of 39UTRs. PLoS ONE, 1:e107. 2006.
144.
MartinouJC, YouleRJ. Which came first, the cytochrome c release or the mitochondrial fission?Cell Death Differ, 13:1291–1295. 2006.
145.
MathupalaSP, KocYH, PerdersenPL. HHexokinase-2 bound to mitochondria: Cancer's stygian link to the “Warburg effect” and a pivotal target for effective therapy. Biochem Biophys Acta, 1797:1225–1230. 2010.
MazurekS, EigenbrodtE. The tumor metabolome. Anticancer Res, 23:1149–1154. 2003.
148.
McCordJM, FridovichI. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein)J Biol Chem, 244:6049–6055. 1969.
149.
McLeodCJ, PagelI, SackMN. The mitochondrial biogenesis regulatory program in cardiac adaptation to ischemia: a putative target for therapeutic intervention. Trends Cardiovasc Med, 15:118–123. 2005.
150.
MedemaRH, KopsGJ, BosJL, BurgeringBM. AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1. Nature, 404:782–787. 2000.
MeiniA, GarciaJB, PessinaGP, AldinucciC, FrosinM, PalmiM. Role of intracellular Ca2+ and calmodulin/MAP kinase kinase/extracellular signal-regulated protein kinase signalling pathway in the mitogenic and antimitogenic effect of nitric oxide in glia- and neurone-derived cell lines. Eur J NeuroSci, 23:1690–1700. 2006.
153.
MeseckeN, TerziyskaN, KozanyC, BaumannF, NeupertW, HellK, HerrmannJM. A disulfide relay system in the intermembrane space of mitochondria that mediates protein import. Cell, 121:1059–1069. 2005.
MitraK, WunderC, RoysamB, LinG, Lippincott-SchwartzJ. A hyperfused mitochondrial state achieved at G1-S regulates cyclin E buildup and entry into S phase. Proc Natl Acad Sci U S A, 106:11960–11965. 2009
156.
MohrJ, MageroyK. Sex-linked deafness of a possibly new type. Acta Genet Statist Med, 10:54–62. 1960.
157.
MöpertK, HajekP, FrankS, ChenC, KaufmannJ, SantelA. Loss of Drp1 function alters OPA1 processing and changes mitochondrial membrane organization. Exp Cell Res, 315:2165–2180. 2009.
158.
Moreno-SánchezR, Rodríguez-EnríquezS, Marín-HernándezA, SaavedraE. Energy metabolism in tumor cells. FEBS J, 274:1393–1418. 2007.
159.
MüllerJM, MilenkovicD, GuiardB, PfannerN, ChacinskaA. Precursor Oxidation by Mia40 and Erv1 Promotes Vectorial Transport of Proteins into the Mitochondrial Intermembrane Space. Mol Biol Cell, 19:226–236. 2008.
160.
MurphyLO, BlenisJ. MAPK signal specificity: the right place at the right time. Trends Biochem Sci, 31:268–275. 2006.
161.
NakamuraT, LiptonSA. Preventing Ca2+-mediated nitrosative stress in neurodegenerative diseases: Possible pharmacological strategies. Cell Calcium, 47:190–197. 2010.
162.
NewmeyerDD, Ferguson-MillerS. Mitochondria: releasing power for life and unleashing the machineries of death. Cell, 112:481–490. 2003.
163.
NewtonAC. Regulation of the ABC kinases by phosphorylation: protein kinase C as a paradigm. Biochem J, 370:361–371. 2003.
164.
NisoliE, ClementiE, MoncadaS, CarrubaMO. Mitochondrial biogenesis as a cellular signaling framework. Biochem Pharmacol, 67:1–15. 2004.
165.
NisoliE, ClementiE, PaolucciC, CozziV, TonelloC, ScioratiC, BracaleR, ValerioA, FrancoliniM, MoncadaS, CarrubaMO. Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide. Science, 299:896–899. 2003.
166.
NowakG, BakajsovaD, CliftonGL. Protein kinase C-epsilon modulates mitochondrial function and active Na+ transport after oxidant injury in renal cells. Am J Physiol Renal Physiol, 286:F307–F316. 2004.
167.
OlichonA, BaricaultL, GasN, GuillouE, ValetteA, BelenguerP, LenaersG. Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis. J Biol Chem, 278:7743–7746. 2003.
168.
OlovnikovIA, KravchenkoJE, ChumakovPM. Homeostatic functions of the p53 tumor suppressor: regulation of energy metabolism and antioxidant defense. Semin Cancer Biol, 19:32–41. 2009.
169.
OrsiA, BeltránB, ClementiE, HallénK, FeelischM, MoncadaS. Continuous exposure to high concentrations of nitric oxide leads to persistent inhibition of oxygen consumption by J774 cells as well as extraction of oxygen by the extracellular medium. Biochem J, 346:407–412. 2000.
170.
Owusu-AnsahE, YavariA, MandalS, BanerjeeU. Distinct mitochondrial retrograde signals control the G1-S cell cycle checkpoint. Nat Genet, 40:356–361. 2008.
171.
Owusu-AnsahE, BanerjeeU. Reactive oxygen species prime Drosophila haematopoietic progenitors for differentiation. Nature, 461:537–541. 2009.
ParkMT, ChoiJA, KimMJ, UmHD, BaeS, KangCM, ChoCK, KangS, ChungHY, LeeYS, LeeSJ. Suppression of extracellular signal-related kinase and activation of p38 MAPK are two critical events leading to caspase-8- and mitochondria-mediated cell death in phytosphingosine-treated human cancer cells. J Biol Chem, 278:50624–50634. 2003.
174.
PearceLR, KomanderD, AlessiDR. The nuts and bolts of AGC protein kinases. Nat Rev Mol Cell Biol, 11:9–22. 2010.
PedrolaL, EspertA, WuX, ClaramuntR, ShyME, PalauF. GDAP1, the protein causing Charcot-Marie-Tooth disease type 4A, is expressed in neurons and is associated with mitochondria. Hum Mol Genet, 14:1087–1094. 2005.
177.
PelicanoH, XuR-H, DuM, FengL, SasakiR, CarewJS, HuY, RamdasL, HuL, KeatingMJ, ZhangW, PlunkettW, HuangP. Mitochondrial respiration defects in cancer cells cause activation of Akt survival pathway through a redox-mediated mechanism. J Cell Biol, 175:913–923. 2006.
178.
PeltenburgLT, de BruinEC, MeersmaD, WiltingS, JürgensmeierJM, SchrierPI. C-Myc is able to sensitize human melanoma cells to diverse apoptotic triggers. Melanoma Res, 14:3–12. 2004.
179.
PengHB, SpieckerM, LiaoJK. Inducible nitric oxide: an autoregulatory feedback inhibitor of vascular inflammation. J Immunol, 161:1970–1976. 1998.
180.
PervinS, SinghR, ChaudhuriG. Nitric oxide-induced cytostasis and cell cycle arrest of a human breast cancer cell line (MDA-MB-231): potential role of cyclin D1. Proc Natl Acad Sci U S A, 98:3583–3588. 2001.
181.
PoderosoC, MalobertiP, DuarteA, NeumanI, PazC, MacielFC, PodestaEJ. Hormonal activation of a kinase cascade localized at the mitochondria is required for StAR protein activity. Mol Cell Endocrinol, 300:37–42. 2009.
182.
PoderosoJJ, CarrerasMC, LisderoCL, RiobóNA, SchöpferF, BoverisA. Nitric oxide inhibits electron transfer and increases superoxide radical production in rat heart mitochondria and submitochondrial particles. Arch Biochem Biophys, 328:85–92. 1996.
183.
PoderosoJJ, CarrerasMC, LisderoC, SchöpferF, RiobóN, GiuliviC, BoverisA, BoverisAA, CadenasE. The reaction of nitric oxide with ubiquinol: kinetic properties and biological significance. Free Rad Biol Med, 26:925–935. 1999.
184.
PoderosoJJ, LisderoC, SchöpferF, RiobóN, CarrerasMC, CadenasE, BoverisA. The regulation of mitochondrial oxygen uptake by redox reactions involving nitric oxide and ubiquinol. J Biol Chem, 274:37709–37716. 1999.
RiobóNA, MelaniM, SanjuanN, FiszmanML, GravielleMC, CarrerasMC, CadenasE, PoderosoJJ. The modulation of mitochondrial nitric-oxide synthase activity in rat brain development. J Biol Chem, 277:42447–42455. 2002.
196.
RobeyR, HayN. Is Akt the Warburg kinase?-Akt-energy metabolism and oncogenesis. Semin Cancer Biol, 19:25–31. 2009.
197.
SablinaAA, BudanovAV, IlyinskayaGV, AgapovaLS, KravchenkoJE, ChumakovPM. The antioxidant function of the p53 tumor suppressor. Nat Med, 11:1306–1313. 2005.
SiderisDP, TokatlidisK. Oxidative protein folding in the intermembrane space. Antioxid Redox Signal, 13:1189–1204. 2010.
208.
SinthupibulyakitC, IttaratW, St. ClairWH, St. ClairDK. p53 Protects lung cancer cells against metabolic stress. Int J Oncol, 37:1575–1581. 2010.
209.
SkeenJE, BhaskarPT, ChenCC, ChenWS, NogueuiraV, Hahn-WindgassenA, KiyokawaH, HayN. Akt deficiency impairs normal cell proliferation and suppresses oncogenesis in a p53-independent and mTOR-dependent manner. Cancer Cell, 10:269–280. 2006.
210.
SkroblinP, GrossmannS, SchäferG, RosenthalW, KlussmannE. Mechanisms of protein kinase a anchoring. Int Rev Cell Mol Biol, 283:235–330. 2010.
211.
StambolicV, SuzukiA, de la PompaJL, BrothersGM, MirtsosC, SasakiT, RulandJ, PenningerJM, SiderovskiDP, MakTW. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell, 95:29–39. 1998.
212.
SteinbergSF. Structural basis of protein kinase C isoform function. Physiol Rev, 88:1341–1378. 2008.
213.
St. PierreJ, DroriS, UldryM, SilvaggiJM, RheeJ, JägerS, HandschinC, ZhengK, LinJ, YangW, SimonDK, BachooR, SpiegelmanBM. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell, 127:397–408. 2006.
SugiokaR, ShimizuS, TsujimotoY. Fzo1, a protein involved in mitochondrial fusion, inhibits apoptosis. J Biol Chem, 279:52726–52734. 2004.
216.
SunQ, ChenX, MaJ, PengH, WangF, ZhaX, WangY, JingY, YangH, ChenR, ChangL, ZhangY, GotoJ, OndaH, ChenT, WangMR, LuY, YouH, KwiatkowskiD, ZhangH. Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth. Proc Nat Acad Sci U S A, 108:4129–4134. 2011.
217.
TaylorRC, CullenSP, MartinSJ. Apoptosis: controlled demolition at the cellular level. Nat Rev Mol Cell Biol, 9:231–241. 2008.
218.
ThiseltonDL, AlexanderC, MorrisA, BrooksS, RosenbergT, EibergH, KjerB, KjerP, BhattacharyaSS, VotrubaM. A frameshift mutation in exon 28 of the OPA1 gene explains the high prevalence of dominant optic atrophy in the Danish population: evidence for a founder effect. Human Genet, 109:498–502. 2001.
219.
TonderaD, CzaudernaF, PaulickK, SchwarzerR, KaufmannJ, SantelA. The mitochondrial protein MTP18 contributes to mitochondrial fission in mammalian cells. J Cell Sci, 118:3049–3059. 2005.
220.
TudzarovaaS, ColomboaSL, StoeberaK, CarcamoaS, WilliamsaGH, MoncadaS. Two ubiquitin ligases, APC/C-Cdh1 and SKP1-CUL1-F (SCF)-β-TrCP, sequentially regulate glycolysis during the cell cycle. Proc Nat Acad Sci USA, 108:5278–5283. 2011.
221.
TurrensJF, BoverisA. Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria. Biochem J, 191:421–427. 1980.
222.
UrtregerAJ, GrossoniVC, FalboKB, KazanietzMG, Bal de Kier JofféED. Atypical protein kinase C-zeta modulates clonogenicity, motility, and secretion of proteolytic enzymes in murine mammary cells. Mol Carcinog, 2:29–39. 2005.
223.
van der LooB, BachschmidM, SkepperJN, LabuggerR, SchildknechtS, HahnR, MüssigE, GygiD, LüscherTF. Age-associated cellular relocation of Sod 1 as a self-defense is a futile mechanism to prevent vascular aging. Biochem Biophys Res Commun, 344:972–980. 2006.
224.
VerkaartS, KoopmWJ, van Emrst-de VriesSE, NijtmansLG, van den HeuvelLW, SmeitinkJA, WillemsPH. Superoxide production is inversely related to complex I activity in inherited complex I deficiency. Biochim Biophys Acta, 1772:373–381. 2007.
225.
VieiraHL, AlvesPM, VercelliA. Modulation of neuronal stem cell differentiation by hypoxia and reactive oxygen species. Progress Neurobiol, 93:444–455. 2011.
226.
VillaloboA. Nitric oxide and cell proliferation. FEBS J, 273:2329–2344. 2006.
227.
WangC, LiZ, LuY, DuR, KatiyarS, YangJ, FuM, LeaderJE, QuongA, NovikoffPM, PestellRG. Cyclin D1 repression of nuclear respiratory factor 1 integrates nuclear DNA synthesis and mitochondrial function. Proc Nat Acad Sci U S A, 103:11567–11572. 2006.
228.
WarburgO, WindF, NegeleinE. On the metabolism of tumors in the body. The Metabolism of Tumors: Investigations from the Kaiser Wilheim Institute for Biology. Berlin-Dahlen, London: Constable & Co., Ltd., 1930.
229.
WarburgO, WindF, NegeleinE. The metabolism of tumors in the body. J Gen Physiol, 8:519–530. 1927.
230.
WasiakS, ZuninoR, McBrideHM. Bax/Bak promote sumoylation of DRP1 and its stable association with mitochondria during apoptotic cell death. J Cell Biol, 177:439–450. 2007.
WestermannB. Mitochondrial fusion and fission in cell life and death. Nature Rev Mol Cell Biol, 11:872–884. 2010.
233.
WestfallSD, SachdevS, DasP, HearneLB, HanninkM, RobertsRM, EzashiT. Identification of oxygen-sensitive transcriptional programs in human embryonic stem cells. Stem Cells Dev, 17:869–881. 2008.
234.
WillisSN, FletcherJI, KaufmannT, van DelftMF, ChenL, CzabotarPE, IerinoH, LeeEF, FairlieWD, BouilletP, StrasserA, KluckRM, AdamsJM, HuangDC. Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak. Science, 315:856–859. 2007.
235.
WilsonJE. Isozymes of mammalian hexokinase: structure, subcellular localization and metabolic function. J Exp Biol, 206:2049–2057. 2003.
236.
WiltshireC, MatsushitaM, TsukadaS, GillespieDA, MayGH. A new c-Jun N-terminal kinase (JNK)-interacting protein, Sab (SH3BP5), associates with mitochondria. Biochem J, 367:577–585. 2002.
237.
YamaguchiR, LartigueL, PerkinsG, ScottRT, DixitA, KushnarevaY, KuwanaT, EllismanMH, NewmeyerDD. Opa1-mediated cristae opening is Bax/Bak and BH3 dependent, required for apoptosis, and independent of Bak oligomerization. Mol Cell, 31:557–569. 2008.
YooY-G, HayashiM, ChristensenJ, HuangLH. An essential role of the HIF-1α–cMyc axis in malignant progression. Ann N Y Acad Sci, 1177:108–204. 2009.
240.
YouleRJ. Cell biology. Cellular demolition and the rules of engagement. Science, 315:776–777. 2007.
241.
YuW, SandersBG, KlineK. RRR-a-tocopheryl succinate induced apoptosis of human breast cancer cells involves Bax translocation to mitochondria. Cancer Res, 63:2483–2491. 2003.
242.
YungHW, WyttenbachA, TolkovskyAM. Aggravation of necrotic death of glucose-deprived cells by the MEK1 inhibitors U0126 and PD184161 through depletion of ATP. Biochem Pharmacol, 68:351–360. 2004.
243.
ZaobornijT, ValdezLB, La PadulaP, CostaLE, BoverisA. Effect of sustained hypobaric hypoxia during maturation and aging on rat myocardium. II. mtNOS activity. J Appl Physiol, 98:2370–2375. 2005.
244.
ZhangL, YuL, YuCA. Generation of superoxide anion by succinate cytochrome c reductase from bovine heart mitochondria. J Biol Chem, 273:33972–33976. 1998.
245.
ZhaoJ, YuanX, FrodinM, GrummtI. ERK-dependent phosphorylation of the transcription initiation factor TIF-IA is required for RNA polymerase I transcription and cell growth. Molecular Cell, 11:405–413. 2003.
246.
ZhouBP, LiaoY, XiaW, SpohnB, LeeMH, HungMC. Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells. Nat Cell Biol, 3:245–252. 2001.
247.
ZorzanoA. Regulation of mitofusin-2 expression in skeletal muscle. Appl Physiol Nutr Metab, 34:433–439. 2009.
248.
ZorzanoA, LiesaM, PalacínM. Role of mitochondrial dynamics proteins in the pathophysiology of obesity and type 2 diabetes. Int J Biochem Cell Biol, 41:1846–1854. 2009.
249.
ZorzanoA, LiesaM, SebastiánD, SegalésJ, PalacínM. Mitochondrial fusion proteins: dual regulators of morphology and metabolism. Semin Cell Dev Biol, 21:566–574. 2010.
250.
ZüchnerS, MersiyanovaIV, MugliaM, Bissar-TadmouriN, RochelleJ, DadaliEL, ZappiaM, NelisE, PatitucciA, SenderekJ, ParmanY, EvgrafovO, JonghePD, TakahashiY, TsujiS, Pericak-VanceMA, QuattroneA, BattalogluE, PolyakovAV, TimmermanV, SchröderJM, VanceJM. Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet, 36:449–451. 2004.